Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Feb 1;102(2):583-593.
doi: 10.1210/jc.2016-2771.

Effects of Testosterone Supplementation for 3 Years on Muscle Performance and Physical Function in Older Men

Affiliations
Randomized Controlled Trial

Effects of Testosterone Supplementation for 3 Years on Muscle Performance and Physical Function in Older Men

Thomas W Storer et al. J Clin Endocrinol Metab. .

Abstract

Context: Findings of studies of testosterone's effects on muscle strength and physical function in older men have been inconsistent; its effects on muscle power and fatigability have not been studied.

Objective: To determine the effects of testosterone administration for 3 years in older men on muscle strength, power, fatigability, and physical function.

Design, setting, and participants: This was a double-blind, placebo-controlled, randomized trial of healthy men ≥60 years old with total testosterone levels of 100 to 400 ng/dL or free testosterone levels <50 pg/mL.

Interventions: Random assignment to 7.5 g of 1% testosterone or placebo gel daily for 3 years.

Outcome measures: Loaded and unloaded stair-climbing power, muscle strength, power, and fatigability in leg press and chest press exercises, and lean mass at baseline, 6, 18, and 36 months.

Results: The groups were similar at baseline. Testosterone administration for 3 years was associated with significantly greater performance in unloaded and loaded stair-climbing power than placebo (mean estimated between-group difference, 10.7 W [95% confidence interval (CI), -4.0 to 25.5], P = 0.026; and 22.4 W [95% CI, 4.6 to 40.3], P = 0.027), respectively. Changes in chest-press strength (estimated mean difference, 16.3 N; 95% CI, 5.5 to 27.1; P < 0.001) and power (mean difference 22.5 W; 95% CI, 7.5 to 37.5; P < 0.001), and leg-press power were significantly greater in men randomized to testosterone than in those randomized to placebo. Lean body mass significantly increased more in the testosterone group.

Conclusion: Compared with placebo, testosterone replacement in older men for 3 years was associated with modest but significantly greater improvements in stair-climbing power, muscle mass, and power. Clinical meaningfulness of these treatment effects and their impact on disability in older adults with functional limitations remains to be studied.

Trial registration: ClinicalTrials.gov NCT00287586.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A) Changes in strength in the chest press exercise. (B) Changes in strength in the leg press exercise. Results represent change in mean maximal voluntary strength from baseline for each visit for men randomly assigned to testosterone (solid line) or placebo arms (dashed line) and the number of subjects completing each visit. Error bars are 95% CIs. P values are provided from linear mixed-model regression controlling for baseline values and age category.
Figure 2.
Figure 2.
(A) Changes for peak power in the chest-press exercise. (B) Changes for peak power in the leg-press exercise. Data indicate changes from baseline in mean peak power for testosterone (solid lines) and placebo (dashed lines) groups for each visit and the number of participants completing each visit (N). Error bars are 95% CIs. P values are provided from linear mixed-model regression controlling for baseline values and age category.
Figure 3.
Figure 3.
Mean changes from baseline at each visit for (A) unloaded and (B) loaded stair climb power. Solid lines represent data for the testosterone group; dashed lines indicate changes in the placebo group. The number of subjects completing each visit (N) is indicated. Error bars are 95% confidence intervals. P values are provided from linear mixed model regression controlling for baseline values and age category.
Figure 4.
Figure 4.
Mean changes in lean body mass from baseline at each visit and the number of subjects at each visit (N). Solid lines represent changes for the testosterone group, and dashed lines indicate changes in the placebo group. Error bars are 95% confidence intervals. P values are provided from linear mixed model regression controlling for baseline values and age category.

Similar articles

Cited by

References

    1. Bhasin S, Pencina M, Jasuja GK, Travison TG, Coviello A, Orwoll E, Wang PY, Nielson C, Wu F, Tajar A, Labrie F, Vesper H, Zhang A, Ulloor J, Singh R, D’Agostino R, Vasan RS. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab. 2011;96(8):2430–2439. - PMC - PubMed
    1. Wu FCW, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, O’Neill TW, Bartfai G, Casanueva FF, Forti G, Giwercman A, Han TS, Kula K, Lean MEJ, Pendleton N, Punab M, Boonen S, Vanderschueren D, Labrie F, Huhtaniemi IT; EMAS Group . Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363(2):123–135. - PubMed
    1. Bhasin S, Woodhouse L, Casaburi R, Singh AB, Mac RP, Lee M, Yarasheski KE, Sinha-Hikim I, Dzekov C, Dzekov J, Magliano L, Storer TW. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab. 2005;90(2):678–688. - PubMed
    1. Krasnoff JB, Basaria S, Pencina MJ, Jasuja GK, Vasan RS, Ulloor J, Zhang A, Coviello A, Kelly-Hayes M, D’Agostino RB, Wolf PA, Bhasin S, Murabito JM. Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study. J Clin Endocrinol Metab. 2010;95(6):2790–2799. - PMC - PubMed
    1. Roy TA, Blackman MR, Harman SM, Tobin JD, Schrager M, Metter EJ. Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men. Am J Physiol Endocrinol Metab. 2002;283(2):E284–E294. - PubMed

Publication types

MeSH terms

Associated data